1. Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptor;Camp;Clin. Cancer Res.,2005
2. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice;Perrotte;Clin. Cancer Res.,1999
3. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor;Ciardiello;Clin. Cancer Res.,2001
4. ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase;Hirata;Cancer Res.,2002